Skip to main content

Table 1 Data on relaxant responses induced by PACAP1–38, PACAP1–27 and VIP performed in vitro on cerebral arteries from different species

From: PACAP and its receptors in cranial arteries and mast cells

Species

PACAP1–38

PACAP1–27

VIP

Reference

pD2

Emax

n

pD2

Emax

n

pD2

Emax

n

Cat

7.9 ± 0.2

24 ± 9

7

7.7 ± 0.4

31 ± 5

7

8.3 ± 0.1

68 ± 8

8

Jansen-Olesen et al. 1994 [46]

Rabbit

n.d.

n.d.

–

8.0 ± 0.1

53 ± 11

6

8.1 ± 0.1

73 ± 5

6

Dalsgaard et al. 2003a [23]

Rat

7.8 ± 0.1

48 ± 7

8

8.0 ± 0.1

51 ± 3

8

8.0 ± 0.2

52 ± 8

7

Baun et al. 2011 [34]

Rat

n.d.

n.d.

–

n.d.

n.d.

–

9.2 ± 0.2

32 ± 1

14

Erdling et al. 2013 [90]

RatPA

7.6 ± 0.2

10 ± 1

5

7.8 ± 0.1

25 ± 1

4

8.7 ± 0.1

28 ± 1

4

Grände et al. 2013 [47]

Human

n.d.

n.d.

–

8.2 ± 0.2

84 ± 9

4

8.8 ± 0.4

84 ± 9

7

Jansen-Olesen et al. 2004 [48]

Human

8.4 ± 0.5

27 ± 8

5

n.d.

n.d.

–

8.1 ± 0.1

57 ± 9

5

Grände et al. 2013 [47]

  1. Data is given as pD2 (negative log concentration inducing half maximum relaxant response), Emax (maximum relaxant response in % of pre-contraction or maximum dilatory capacity), n = number of experiments
  2. PAPressurized arteriography abluminal application
  3. aPACAP1–27 was used because it induced a stronger response than PACAP1–38